Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
MEK inhibitor.
Polyphenolic compound present in black tea.
SV2A synaptic vesicle inhibitor.
Impurity of diclofenac
Cannabinoid receptor 2 selective agonist.
Quinoline; PDE 3B inhibitor.
β-adrenergic agonist.
Alkaloid found in Cephalotaxus; ribosomal prote...
HDAC inhibitor, mammalian RNA splicing modulato...
Wee1 inhibitor.
1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhi...
Prostacyclin analog
Thiazide-like diuretic; Kv7.1 and minK K+ chann...
Peptide toxin found in Conus snails; nAChR inhi...
Alkaloid found in Catharanthus, precursor in sy...
Microtubule polymerization inhibitor, potential...
Triterpene saponin found in species of Panax. <...
Spirodihydrobenzofuranlactam
5-HT3 antagonist.
Steroid; glucocorticoid agonist.